Phase 2 Study of Sildenafil for the Treatment of Lymphatic Malformations
Latest Information Update: 21 Nov 2022
At a glance
- Drugs Sildenafil (Primary)
- Indications Lymphatic disorders
- Focus Therapeutic Use
- 25 Oct 2022 Status changed from active, no longer recruiting to completed.
- 25 Feb 2022 Planned End Date changed from 1 Dec 2022 to 1 Aug 2023.
- 11 Jan 2022 Status changed from recruiting to active, no longer recruiting.